Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001447028-20-000041
Filing Date
2020-03-06
Accepted
2020-03-06 16:06:45
Documents
4
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A a201910-ka.htm 10-K/A 40975
2 EXHIBIT 23.1 a201910-kaxex231.htm EX-23.1 4263
3 EXHIBIT 31.1 a201910-kaxex311.htm EX-31.1 8349
4 EXHIBIT 31.2 a201910-kaxex312.htm EX-31.2 7605
  Complete submission text file 0001447028-20-000041.txt   62360
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

EIN.: 980597776 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-34949 | Film No.: 20694795
SIC: 2834 Pharmaceutical Preparations